
Overview
Dr. Hatem Hassanein is a board-certified and fellowship-trained hematologist and urologic medical oncologist at the Orlando Health Cancer Institute. He specializes in general hematology and urologic oncology. He diagnoses and treats patients with urologic cancers, including prostate, bladder, kidney and testicular, as well as patients with malignant and non-malignant hematologic disorders. His specialties also include: Chemotherapy Immunotherapy Hormone-based therapies Genetically targeted therapies Dr. Hassanein’s Training Dr. Hassanein earned his medical degree and completed an internal medicine residency at the University of South Florida Morsani College of Medicine in Tampa. He performed a fellowship in hematology and oncology at the Orlando Health Cancer Institute. About Dr. Hassanein Dr. Hassanein is board certified in internal medicine by the American Board of Internal Medicine. He is a member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. He has been published in several medical journals and given presentations to national and international symposiums.
Dr. Hassanein is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Familial Wilms Tumor 2, WT1-Related Wilms Tumor Syndromes, and Embolectomy.
He is actively involved in clinical research, co-authoring 6 peer reviewed articles.
Graduate Institution
Residency
Specialties
Licenses
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1400 S. Orange Ave., Orlando, FL 32806
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Orlando Health Cancer Institute - Downtown Orlando
Jennifer Tseng, MD, hematologist/medical oncologist, is the Thoracic/Head and Neck Specialty Section leader for Medical Oncology and the associate director of Clinical Research for Medical Oncology at Orlando Health Cancer Institute.Dr. Tseng received her medical degree from Duke University School of Medicine. She completed her residency and served as assistant chief resident in internal medicine at Duke University Medical Center. She completed a fellowship in medical oncology and hematology at The University of Texas MD Anderson Cancer Center in Houston. She is board-certified in internal medicine and medical oncology and board-eligible in hematology. Dr. Tseng has received several honors and awards, including the C.D. Howe Award for clinical excellence in medical oncology and a Clinical Research Award from MD Anderson, the American Medical Women's Award, Hewlett Packard Award, the Alpha Omega Alpha Research Symposium Award from Duke University and a Beneficial-Hodgson scholarship from The Johns Hopkins University. She was also awarded Attending of the Year from the Internal Medicine Residency Program from Orlando Regional Medical Center and received the Exemplary Physician Colleague Award from Orlando Health in 2009.In addition to her clinical studies, Dr. Tseng has published research on various topics including molecular alterations in lung cancer and novel agents in the treatment of head and neck cancer. She has recently presented at the Annual Thoracic Oncology Symposium of the Puerto Rican Society of Hematology Oncology and spoke on neoadjuvant and adjuvant treatment strategies in lung cancer. Dr. Tseng is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Lung Adenocarcinoma. Dr. Tseng is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine.
Orlando Health Cancer Institute - Downtown Orlando
Dr. Tirrell Johnson is a board-certified medical oncologist at the Orlando Health Cancer Institute. His specialties include: Head and neck cancers Thoracic cancers Melanoma Sarcoma He is a member of the team pioneering a breakthrough protocol using tumor-infiltrating lymphocytes to address aggressive, late-stage melanoma. Dr. Johnson's Training Dr. Johnson earned a bachelor's degree in chemical engineering from Florida A&M University in Tallahassee, graduating magna cum laude, and received his medical degree from the University of Florida in Gainesville. He completed an internal medicine residency at Orlando Health Orlando Regional Medical Center and a fellowship in hematology and oncology at Brown University Medical School's teaching hospitals in Providence, Rhode Island. About Dr. Johnson Dr. Johnson is board certified in internal medicine and medical oncology by the American Board of Internal Medicine. His professional memberships include the American College of Physicians, American Society of Clinical Oncology and American Society of Hematology. Dr. Johnson received an Orlando Health award for outstanding multidisciplinary involvement with staff. He has served as the primary investigator for clinical trials studying several forms of chemotherapy for advanced head and neck cancers and thoracic malignancies. Dr. Johnson is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Johnson is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine.
Florida Cancer Specialists & Research Institute, LLC
Sonalee Shroff is a Hematologist and an Oncologist practicing medicine in Winter Park, Florida. Dr. Shroff is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Shroff is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine - Hematology.
Frequently Asked Questions about Dr. Hatem Hassanein
How do I make an appointment with Dr. Hatem Hassanein?
You can book an appointment with Dr. Hatem Hassanein by calling their office at 321-841-1869. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Hatem Hassanein a top-rated expert for Familial Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Hatem Hassanein is classified as an Advanced expert for Familial Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Hatem Hassanein specialize in?
While Dr. Hatem Hassanein is a Hematology, they have specific expertise in Familial Prostate Cancer, Prostate Cancer, and Embolectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Hatem Hassanein participate in research or clinical trials?
Yes. Dr. Hatem Hassanein has published 6 articles and abstracts on conditions like Familial Prostate Cancer. You can view a list of Dr. Hatem Hassanein's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Hatem Hassanein accept my insurance?
Dr. Hatem Hassanein accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 321-841-1869 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial Prostate CancerDr. Hassanein isAdvanced. Learn about Familial Prostate Cancer.
- Prostate CancerDr. Hassanein isAdvanced. Learn about Prostate Cancer.
- Experienced
- Adult Soft Tissue SarcomaDr. Hassanein isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AnemiaDr. Hassanein isExperienced. Learn about Anemia.
- B-Cell LymphomaDr. Hassanein isExperienced. Learn about B-Cell Lymphoma.
- Bladder CancerDr. Hassanein isExperienced. Learn about Bladder Cancer.
- ChoriocarcinomaDr. Hassanein isExperienced. Learn about Choriocarcinoma.
- Chromophobe Renal Cell CarcinomaDr. Hassanein isExperienced. Learn about Chromophobe Renal Cell Carcinoma.

